Site Ref # / Investigator 1722 — Omaha, Nebraska

Site Ref # / Investigator 1722 is a clinical research site located in Omaha, Nebraska, United States 68134.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site Ref # / Investigator 1722 has participated in 1 clinical trials.

Therapeutic areas: Moderate to Severe Chronic, Non-malignant Pain.

Sponsors: Abbott.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Ref # / Investigator 1722?

Site Ref # / Investigator 1722 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Ref # / Investigator 1722 conducted?

Site Ref # / Investigator 1722 has 1 clinical trials on record. Their work covers Moderate to Severe Chronic, Non-malignant Pain.

Is Site Ref # / Investigator 1722 accredited by Crixeo Health?

Site Ref # / Investigator 1722 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Ref # / Investigator 1722?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.